Educational Activities

Show Filters
Hide Filters
1-6 of 6 Activities
Title
Availability
Format
Credits
Course Opens
Buttons

Efficacy and Safety of Asparaginase-Containing Treatment Regimens in ALL/LBL and Beyond – An Interactive Review for Oncology Nurses and Nurse Practitioners

This CEC Oncology ONS Chapters Series is targeted to oncology nurses and advanced nurse practitioners serving as part of an interprofessional healthcare team providing care for pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL).

This activity is no longer available for credit.
1.0
03/14/2023

Sandra Kurtin, PhD, ANP-C, AOCN

Sandra Kurtin, PhD, ANP-C, AOCN

All Hands on Deck in Cervical Cancer Care: Screening, Treatment, and Equity Strategies to Improve Patient Lives

In this CE Concepts recorded webcast, expert faculty will guide learners on the implementation of recommended, inclusive, and universal screening techniques and programs for cervical cancer. Faculty will also evaluate the latest efficacy and safety data in different settings for the treatment of cervical cancer as well as incorporate actionable strategies to address disparities and the unique health care of individuals with marginalized sexualities and genders related to cervical cancer screening.

1
10/01/2024

Mollie Aleshire, DNP, MSN, APRN, FNP-BC, PPCNP-BC, FNAP

Mollie Aleshire, DNP, MSN, APRN, FNP-BC, PPCNP-BC, FNAP

Bradley J. Monk, MD, FACS, FACOG

Bradley J. Monk, MD, FACS, FACOG

Nicoletta Colombo, MD, PhD

Nicoletta Colombo, MD, PhD

Moderator

On-Demand
CME Snack
1
03/17/2025

The Promise of Folate Receptor Alpha-Targeting ADCs for Platinum-Resistant Ovarian Cancer

In this CE Concepts Snack, expert faculty will address critical gaps in clinician knowledge and competence by equipping learners with strategies to categorize treatment options and optimize patient-specific care plans incorporating novel therapies. Faculty will also explore approaches to mitigating disparities in ovarian cancer care, ensuring learners can implement equitable, evidence-based practices that enhance patient outcomes. 

1
03/17/2025

Elizabeth (Betsy) Lee, MD

Elizabeth (Betsy) Lee, MD

Kathleen N. Moore, MD, MS, FASCO

Kathleen N. Moore, MD, MS, FASCO

Moderator

On-Demand
BriefCase
0.5
06/26/2025

ADCs and Chemotherapy: More Different Than You Might Expect in HER2-Negative MBC

In the first of this 3-part CEC Oncology BriefCase series, expert faculty introduce clinicians to ADC therapy for HER2-negative MBC and hear from a patient advocate about patient concerns regarding this new therapy option.

0.5
06/26/2025

Danielle Roman, PharmD, BCOP

Danielle Roman, PharmD, BCOP

Michelle Anderson-Benjamin, MHA

Michelle Anderson-Benjamin, MHA

Rita Nanda, MD, FASCO

Rita Nanda, MD, FASCO

Moderator

On-Demand
BriefCase
0.5
07/02/2025

Clinical Trial Data with ADCs: New Options for HER2-Negative MBC

In the second of this 3-part CEC Oncology BriefCase series, expert faculty review emerging data on ADC therapy for HER2-negative MBC, describe therapy selection and treatment sequencing rationale, and hear from a patient advocate about patient concerns regarding this new therapy option.

0.5
07/02/2025

Reshma L. Mahtani, DO

Reshma L. Mahtani, DO

Michelle Anderson-Benjamin, MHA

Michelle Anderson-Benjamin, MHA

Rita Nanda, MD, FASCO

Rita Nanda, MD, FASCO

Moderator

On-Demand
BriefCase
0.5
07/02/2025

Maintaining Patient QoL through Optimal Management of ADC-Associated AEs

In the third of this 3-part CEC Oncology BriefCase series, expert faculty and a patient advocate delve into interprofessional strategies for preventing and mitigating adverse events while collaboratively promoting QoL for patients being treated for HER2-negative MBC.

0.5
07/02/2025

Jennifer McKenna, RN, MSN, AOCNP

Jennifer McKenna, RN, MSN, AOCNP

Michelle Anderson-Benjamin, MHA

Michelle Anderson-Benjamin, MHA

Rita Nanda, MD, FASCO

Rita Nanda, MD, FASCO

Moderator